ENT
ActiveSummary
ENT has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €72,979 and a net result of -€29,999. Equity is shrinking by ~21.8% per year across the filed fiscal years. Its solvency ranks better than 9% of 19918 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability10▼-1
Solvency34▼-3
Growth26▼-1
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €3,500 at 30 days acceptable
Liquidity short (current ratio 0.12 against 0.05 in 2023; short-term debt: 35.7% and cash: 1.1% of total assets), and 91.4% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
8.6%
Return on assets
-3.5%
Age of the figures
21 mo
raises risk · Persistent losses
Two consecutive loss-making years (2023 and 2024); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2024Net result per financial year
18192021222324
2018 to 2024 · latest year -€29,999
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 9% of 19918 sector peers (2024).
NBB · sector comparisonPosition among 19918 sector peers
Solvency
better than 9%
← weakest
strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 12-09-2025, 43 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
43 d late
2023
113 d late
2022
43 d late
2021
115 d late
2020
135 d late
2019
137 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 98 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, micro schema
Turnover
€221,428▼ 6.6%
2023 · €237,028
EBIT margin
-8.9%▲ 5.9pp
2023 · -14.8%
Net result
-€29,999▲ 37.7%
2023 · -€48,180
Working capital
-€267,696▲ 52.5%
2023 · -€563,639
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Turnover€328,056▲ 10.0%€200,153▼ 39.0%€253,713▲ 26.8%€237,028▼ 6.6%€221,428▼ 6.6%
Operating result€430▼ 97.9%-€76,134-€8,682▲ 88.6%-€35,129▼ 305%-€19,777▲ 43.7%
Net result-€13,318below the sector's middle half-€89,954below the sector's middle half▼ 575%-€21,378below the sector's middle half▲ 76.2%-€48,180below the sector's middle half▼ 125%-€29,999below the sector's middle half▲ 37.7%
EBIT margin0.1%▼ 6.7pp-38.0%▼ 38.2pp-3.4%▲ 34.6pp-14.8%▼ 11.4pp-8.9%▲ 5.9pp
Equity€262,490within the sector's middle half▼ 4.8%€172,536within the sector's middle half▼ 34.3%€151,158within the sector's middle half▼ 12.4%€102,978within the sector's middle half▼ 31.9%€72,979within the sector's middle half▼ 29.1%
Total assets€916,747within the sector's middle half▲ 6.4%€897,914within the sector's middle half▼ 2.1%€895,239above the sector's middle half▼ 0.3%€842,656above the sector's middle half▼ 5.9%€849,131above the sector's middle half▲ 0.8%
Debt€654,258▲ 11.7%€725,378▲ 10.9%€744,082▲ 2.6%€739,678▼ 0.6%€776,152▲ 4.9%
Working capital-€305,660▼ 28.7%-€435,621▼ 42.5%-€488,985▼ 12.3%-€563,639▼ 15.3%-€267,696▲ 52.5%
Solvency28.6%within the sector's middle half▼ 3.4pp19.2%below the sector's middle half▼ 9.4pp16.9%below the sector's middle half▼ 2.3pp12.2%below the sector's middle half▼ 4.7pp8.6%below the sector's middle half▼ 3.6pp
Staff (FTE)1.8within the sector's middle half=1.3below the sector's middle half▼ 27.8%1.3=1.3=1.3=
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €19,777 in 2024 against €35,129 in 2023; the loss shrinks.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €849,131
Fixed assets
€813,408 =
Current assets
€35,723 ▲ 22.7%
Equity and liabilities €849,131
Equity
€72,979 ▼ 29.1%
Debt
€776,152 ▲ 4.9%
Debt's share of the balance-sheet total rises from 87.8% to 91.4%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
-€11,945▼
2023 · -€6,793
Cash flow
-€22,167▼
2023 · -€19,844
Current ratio
0.12▲
2023 · 0.05
Debt to equity
10.64▲
2023 · 7.18
ROE
-41.1%▲
2023 · -46.8%
ROA
-3.5%▲
2023 · -5.7%
Interest coverage
-1.17▼
2023 · -0.56
Debt ≤ 1 year
€303,419▼
2023 · €592,751
Debt > 1 year
€95,513▼
2023 · €146,927
Income taxes
€0▼
2023 · €1,116
Staff costs
€108,619▲
2023 · €104,988
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Turnover70 | €328,056 | €200,153 | €253,713 | €237,028 | €221,428 | ▼ 6.6% |
| Goods, raw materials, services and sundry goods60/61 | - | €160,090 | €152,957 | €142,696 | €221,644 | ▲ 55.3% |
| Remuneration, social security and pensions62 | - | €87,059 | €98,620 | €104,988 | €108,619 | ▲ 3.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €26,869 | €26,864 | €31,454 | €28,336 | €7,832 | ▼ 72.4% |
| Other operating charges640/8 | - | €1,400 | €1,322 | €980 | €4,776 | ▲ 388% |
| Non-recurring operating charges66A | - | €2,245 | €1,334 | €1,083 | €810 | ▼ 25.2% |
| Gross operating margin9900 | €139,375 | €41,433 | €124,047 | €100,257 | €102,260 | ▲ 2.0% |
| Operating profit (loss)9901 | €430 | -€76,134 | -€8,682 | -€35,129 | -€19,777 | ▲ 43.7% |
| Financial income75/76B | - | €221 | €69 | €157 | €3 | ▼ 98.0% |
| Recurring financial income75 | €19 | €221 | €69 | €157 | €3 | ▼ 98.0% |
| Financial charges65/66B | - | €12,963 | €12,766 | €12,092 | €10,225 | ▼ 15.4% |
| Recurring financial charges65 | €11,286 | €12,963 | €12,766 | €12,092 | €10,225 | ▼ 15.4% |
| Profit (loss) for the period before taxes9903 | -€10,837 | -€88,877 | -€21,378 | -€47,064 | -€29,999 | ▲ 36.3% |
| Income taxes67/77 | €2,481 | €1,076 | - | €1,116 | €0 | ▼ 100% |
| Profit (loss) for the period9904 | -€13,318 | -€89,954 | -€21,378 | -€48,180 | -€29,999 | ▲ 37.7% |
| Profit (loss) for the period to be appropriated9905 | -€13,318 | -€89,954 | -€21,378 | -€48,180 | -€29,999 | ▲ 37.7% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €916,747 | €897,914 | €895,239 | €842,656 | €849,131 | ▲ 0.8% |
| Formation expenses20 | €0 | €0 | €0 | €0 | €0 | - |
| Fixed assets21/28 | €876,418 | €868,114 | €841,879 | €813,544 | €813,408 | = |
| Intangible fixed assets21 | €0 | €0 | €0 | €0 | €0 | - |
| Tangible fixed assets22/27 | €73,948 | €65,643 | €39,409 | €11,073 | €10,938 | ▼ 1.2% |
| Land and buildings22 | - | €1,298 | €626 | €312 | €8 | ▼ 97.4% |
| Plant, machinery and equipment23 | - | €6,768 | €6,461 | €4,474 | €4,841 | ▲ 8.2% |
| Furniture and vehicles24 | - | €57,577 | €32,322 | €6,288 | €6,088 | ▼ 3.2% |
| Financial fixed assets28 | €802,470 | €802,470 | €802,470 | €802,470 | €802,470 | = |
| Current assets29/58 | €40,329 | €29,800 | €53,360 | €29,112 | €35,723 | ▲ 22.7% |
| Amounts receivable within one year40/41 | €39,560 | €29,260 | €29,297 | €25,933 | €26,450 | ▲ 2.0% |
| Trade receivables40 | - | €12,610 | €5,147 | €6,783 | €7,300 | ▲ 7.6% |
| Other amounts receivable41 | - | €16,650 | €24,150 | €19,150 | €19,150 | = |
| Cash at bank and in hand54/58 | €769 | €540 | €24,063 | €3,179 | €9,273 | ▲ 192% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €916,747 | €897,914 | €895,239 | €842,656 | €849,131 | ▲ 0.8% |
| Equity10/15 | €262,490 | €172,536 | €151,158 | €102,978 | €72,979 | ▼ 29.1% |
| Contributions10/11 | €20,000 | €20,000 | €20,000 | €20,000 | €20,000 | = |
| Capital10 | - | €20,000 | €20,000 | - | - | - |
| Issued capital100 | - | €20,000 | €20,000 | - | - | - |
| Reserves13 | €2,000 | €2,000 | €2,000 | €2,000 | €2,000 | = |
| Non-distributable reserves130/1 | - | €2,000 | €2,000 | €2,000 | €2,000 | = |
| Legal reserve130 | - | €2,000 | €2,000 | - | - | - |
| Reserves not available under the articles1311 | - | - | - | €2,000 | €2,000 | = |
| Profit (loss) carried forward14 | €240,490 | €150,536 | €129,158 | €80,978 | €50,979 | ▼ 37.0% |
| Amounts payable17/49 | €654,258 | €725,378 | €744,082 | €739,678 | €776,152 | ▲ 4.9% |
| Amounts payable after more than one year17 | €308,268 | €259,956 | €201,737 | €146,927 | €95,513 | ▼ 35.0% |
| Financial debts170/4 | - | €259,956 | €201,737 | €146,927 | €95,513 | ▼ 35.0% |
| Amounts payable within one year42/48 | €345,990 | €465,422 | €542,345 | €592,751 | €303,419 | ▼ 48.8% |
| Current portion of amounts payable after more than one year42 | - | €62,564 | €58,220 | €54,810 | €48,372 | ▼ 11.7% |
| Financial debts43 | - | €17,656 | €26,835 | €25,466 | €400 | ▼ 98.4% |
| Credit institutions430/8 | - | €17,656 | €26,835 | €25,466 | €400 | ▼ 98.4% |
| Trade debts44 | €20,793 | €0 | €16,830 | €24,029 | €30,784 | ▲ 28.1% |
| Suppliers440/4 | - | €0 | €16,830 | €24,029 | €30,784 | ▲ 28.1% |
| Taxes, remuneration and social security45 | - | €12,006 | €11,614 | €14,513 | €11,614 | ▼ 20.0% |
| Taxes450/3 | - | €0 | €0 | €0 | €0 | - |
| Remuneration and social security454/9 | - | €12,006 | €11,614 | €14,513 | €11,614 | ▼ 20.0% |
| Other amounts payable47/48 | - | €373,196 | €428,846 | €473,933 | €212,248 | ▼ 55.2% |
| Accrued charges and deferred income492/3 | - | - | - | - | €377,220 | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€13,318 | -€89,954 | -€21,378 | -€48,180 | -€29,999 | ▲ 37.7% |
| + Depreciation and write-downs630 | €26,869 | €26,864 | €31,454 | €28,336 | €7,832 | ▼ 72.4% |
| Operating cash flow (approximation) | €13,551 | -€63,090 | €10,075 | -€19,844 | -€22,167 | ▼ 11.7% |
| Investment in fixed assets (approximation) | - | -€18,560 | -€5,219 | €0 | -€7,697 | - |
| Change in cash | - | -€229 | €23,523 | -€20,884 | €6,094 | ▲ 129% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
12-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 43 days late
2024
21-11
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 113 days late
2023
12-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 43 days late
2022
23-11
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 115 days late
2021
31-12
Financial
Weakest financial yearnet -€89,954
Net result drops to -€89,954, the lowest in the series; recovery starts the following year.
13-12
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 135 days late
2020
15-12
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 137 days late
2019
31-12
Financial
Back to profitnet €5,901
Net result €5,901 after one loss-making year.
12-12
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 134 days late
2018
19-12
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 141 days late
2017
08-11
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 100 days late
2016
18-11
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 110 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Anderlecht · 1 establishment unit since 2005
Ground area
783 m²
Building footprint
164 m²
Volume, LiDAR
1,469 m³
Parcel 21302A0120/00E007, Brussels · tallest building 13.0 m, ±3 floors. Linked by address, not a title deed.
6
companies at this address
See who is registered here
1 establishment unit
Krokussenlaan 11, 1070 Anderlecht
since 20052.229.496.302
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21302A0120/00E007 | Brussels | 783 m² | 1 · 164 m² | 13.0 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DOCTEUR PATRIS MARIE GYNECOLOGIE SRL
BE 0802.462.885
Beloeil · Eq €72,984
MARTY Médicale
BE 0778.411.538
Ottignies-Louvain-la-Neuve · Eq €72,961
Dokter Annelien VAN DRIESSCHE, gastro-enteroloog
BE 0677.900.732
Ronse · Eq €72,959
Centre de médecine spécialisée du Docteur Philippe PETIT
BE 0862.137.780
Neupré · Eq €73,011
Delladerma
BE 1004.877.735
Antwerpen · Eq €72,940
Of 16,631 companies in sector 86220 we hold annual accounts for 7,985. 5,789 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded18-04-2005
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Contact
E-mail
stef.res@skynet.beAnderlecht
Phone
0475/24.60.17Anderlecht
E-invoicing
Not found in the Peppol register
No Peppol card under this enterprise or VAT number. That proves nothing: publishing a card is voluntary.
What can you do?
Try sending from your invoicing software; if that fails, ask the customer whether they already receive via Peppol.
If the customer is not ready yet, you may send the invoice another way, for example as a PDF; if electronically, with their agreement on a secure alternative. That invoice is valid; the customer risks a penalty. FPS Finance
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.